Serum ferritin and malignant tumours.

Area of Science:

• Biochemistry
• Oncology
• Clinical Chemistry

Background:

• Serum ferritin concentrations are frequently elevated in patients with malignant diseases.
• This elevation is generally considered a non-specific response to cancer.

Purpose of the Study:

• To evaluate the utility of serum ferritin assays in the specific diagnosis of malignant disease.
• To assess the role of serum ferritin in monitoring cancer progression or treatment response.
• To investigate the potential significance of acidic isoferritins in the context of malignancy.

Main Methods:

• Review of existing evidence on serum ferritin levels in cancer patients.
• Analysis of the diagnostic and monitoring capabilities of serum ferritin assays.
• Examination of studies investigating acidic isoferritin isoforms.

Main Results:

• Current evidence indicates that increased serum ferritin is a non-specific finding in malignancy.
• Serum ferritin assays lack utility for specific cancer diagnosis.
• The use of serum ferritin for monitoring malignant disease is not supported by present data.

Conclusions:

• Serum ferritin is not a reliable biomarker for the specific diagnosis or monitoring of malignant diseases.
• The specialized role of acidic isoferritins in malignancy requires further substantiation through rigorous research.